683 Capital Management, LLC Tg Therapeutics, Inc. Transaction History

683 Capital Management, LLC

$1.17 Billion
Q1 2024

A detailed history of 683 Capital Management, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, 683 Capital Management, LLC holds 1,625,000 shares of TGTX stock, worth $28.9 Million. This represents 2.11% of its overall portfolio holdings.

Number of Shares

1,625,000

Previous 1,675,000 2.99%

Holding current value

$28.9 Million

Previous $28.6 Million 13.6%

% of portfolio

2.11%

Previous 2.93%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$13.02 - $21.3 $651,000 - $1.07 Million	-50,000 Reduced 2.99%	1,625,000 $24.7 Million
Q4 2023 Feb 14, 2024	BUY	$6.68 - $18.81 $2.17 Million - $6.11 Million	325,000 Added 24.07%	1,675,000 $28.6 Million
Q3 2023 Nov 14, 2023	BUY	$8.36 - $26.5 $11.3 Million - $35.8 Million	1,350,000 New	1,350,000 $11.3 Million
Q1 2023 May 15, 2023	SELL	$10.23 - $19.34 $4.86 Million - $9.19 Million	-475,000 Reduced 38.0%	775,000 $11.7 Million
Q4 2022 Feb 14, 2023	SELL	$5.01 - $11.83 $7.69 Million - $18.1 Million	-1,534,000 Reduced 55.1%	1,250,000 $14.8 Million

Q3 2022 Nov 14, 2022	SELL	$4.57 - $8.4 $2.36 Million - $4.33 Million	-516,000 Reduced 15.64%	2,784,000 $16.5 Million
Q2 2022 Aug 15, 2022	BUY	$3.74 - $10.66 $2.62 Million - $7.47 Million	701,105 Added 26.98%	3,300,000 $14 Million
Q1 2022 May 16, 2022	BUY	$7.81 - $20.45 $10.9 Million - $28.5 Million	1,391,895 Added 115.32%	2,598,895 $24.7 Million
Q4 2021 Feb 14, 2022	BUY	$15.2 - $35.51 $5.76 Million - $13.4 Million	378,729 Added 45.73%	1,207,000 $22.9 Million
Q3 2021 Nov 15, 2021	BUY	$21.78 - $40.45 $12.7 Million - $23.7 Million	585,000 Added 240.47%	828,271 $27.6 Million
Q1 2021 May 17, 2021	SELL	$41.61 - $54.3 $6.45 Million - $8.42 Million	-155,000 Reduced 38.92%	243,271 $11.7 Million
Q4 2019 Feb 14, 2020	SELL	$5.1 - $11.2 $8,817 - $19,364	-1,729 Reduced 0.43%	398,271 $4.42 Million
Q3 2019 Nov 14, 2019	SELL	$5.38 - $8.99 $511,100 - $854,050	-95,000 Reduced 19.19%	400,000 $2.25 Million
Q2 2019 Aug 14, 2019	SELL	$6.27 - $8.65 $188,100 - $259,500	-30,000 Reduced 5.71%	495,000 $4.28 Million
Q1 2019 May 15, 2019	BUY	$4.02 - $8.04 $100,499 - $200,999	25,000 Added 5.0%	525,000 $4.22 Million
Q3 2018 Nov 14, 2018	BUY	$5.15 - $14.0 $2.58 Million - $7 Million	500,000 New	500,000 $2.8 Million

Others Institutions Holding TGTX

# of Institutions

269

Shares Held

87.7M

Call Options Held

2.72M

Put Options Held

1.74M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $2.58B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 683 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 683 Capital Management, LLC with notifications on news.

Account

683 Capital Management, LLC Tg Therapeutics, Inc. Transaction History